abstract |
Compounds of the formula: n nor pharmaceutically acceptable salts, solvates or prodrugs thereof,n nwherein Ar, R 1 and R 2 are defined herein. Also provided are pharmaceutical compositions, methods of preparing the compounds, and method of using the compounds for treatment of monoamine reuptake inhibitor-mediated diseases. |